Dr. Timothy G. Ferris Named Board Chair

Earlier today, during Health Catalyst, Inc.’s (“Health Catalyst”) Q4 2020 earnings call, Dan Burton, CEO of Health Catalyst, shared that Dr. Timothy G. Ferris, M.D., has been appointed to Chair of the Board of Directors effective March 1, 2021.

“I am grateful for Dr. Ferris’ alignment to our mission, our cultural attributes, and our operating principles. I anticipate that Dr. Ferris’ unique perspective will continue to add significant insights and ideas during this next phase of our company’s journey as he helps us increasingly appreciate the most significant challenges facing healthcare organizations,” said Burton.

Dr. Ferris has served as a member of Health Catalyst’s Board of Directors since January 2018. He will succeed Fraser Bullock, who has served as Health Catalyst’s Chair since 2014 and will continue to serve on the Board.

“The company’s mission-orientation, culture, and commitment to team members and clients are refreshing and drive meaningful and innovative healthcare improvements. I look forward to contributing to the vision for ongoing transformative technological solutions that improve data-informed decision-making for the healthcare ecosystem,” said Dr. Ferris.

Dr. Ferris is Chief Executive Officer of the Massachusetts General Physicians Organization, a multi-specialty medical group, and has been in this leadership role since 2017. Prior to that, he was the Senior Vice President for Population Health at Partners HealthCare and Massachusetts General Hospital, from 2011 to 2017. Dr. Ferris holds a B.A. from Middlebury College, an M.Phil. from Wolfson College, Oxford University, an M.D. from Harvard Medical School, and an M.P.H. from Harvard School of Public Health.

In his comments, Burton also shared his deep gratitude to Bullock for his significant contributions to the company in his role as Chair.

“Over the past seven years Fraser’s leadership has been instrumental in guiding our growth and development, and we’re grateful to continue to benefit from his insights and experience as a board member.”

A full recap of Health Catalyst’s updates and growth reported during its Q4 2020 earnings call can be found here.